Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-11-21

FDA Approved: KETOROLAC TROMETHAMINE — Supplemental Application (Eugia US LLC)

View source ↗

Summary

FDA approved a supplemental application for Ketorolac tromethamine (generic) from Eugia US LLC under ANDA 212939.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketorolac tromethamine (Ketorolac tromethamine)

Snippet

SUPPL AP for KETOROLAC TROMETHAMINE (KETOROLAC TROMETHAMINE)